Newsroom

Oct 09 2018

1

New Clinical Trial Studies Cardio-Inflammatory Health

By Cardax | Management Insights, Media Mentions

David G. Watumull, CEO of Cardax, was on Hawaii News Now Sunrise to discuss Cardax's new clinical trial studying the effects of astaxanthin on cardio-inflammatory health.

Sep 27 2018

2

Cardax CEO Featured on Big Biz TV Show

By Cardax | Management Insights, Media Mentions | No Comments

Cardax CEO, David G. Watumull, was featured Friday, September 21, 2018, on the business television and radio show, The Big Biz Show. The show is simulcast on television and radio...

Dec 05 2017

2

Setting the record straight about ZanthoSyn®

By Cardax | Management Insights

False and baseless assertions about our dietary supplement ZanthoSyn® have recently been in the news, so we want to set the record straight about its anti-inflammatory health benefits, safety, and...

Jul 12 2017

2

The Secret to a Longer Life

https://cardaxpharma.com/wp-content/uploads/2017/07/MidWeek-Cover-Story_Cardax-UH-Longevity_2017-07-12.pdf

Jun 20 2017

1

NIH selection propels Cardax towards expansion

http://www.bizjournals.com/pacific/news/2017/06/20/nih-selection-propels-cardax-towards-expansion.html

Mar 29 2017

1

Compound boosts gene related to longevity, UH researchers find

https://cardaxpharma.com/wp-content/uploads/2017/03/Compound-Boosts-Gene-Related-to-Longevity-UH-Researchers-Find.pdf

Mar 28 2017

0

Promising anti-aging gene therapy developed through innovative partnership

http://www.hawaii.edu/news/2017/03/28/astaxanthin-therapy/

Mar 28 2017

0

Extending human life: UH scientists announce new research

http://www.kitv.com/story/35017622/extending-human-life-uh-scientists-announce-new-research

Mar 28 2017

0

UH study: Compound found in seafood, algae ‘activates’ longevity gene

http://www.hawaiinewsnow.com/story/35018512/study-compound-found-in-seafood-algae-activates-longevity-gene

Aug 04 2016

2

Cardax’s Proprietary Astaxanthin Prodrug (CDX-085) Accumulates in Liver, Reduces Elevated Liver Enzymes, and Attenuates Pathohistological Alterations in a Model of Alcohol-Induced Hepatic Stress

By Cardax | Science

In collaboration with Dr. Steven Weinman, M.D., Ph.D. (Director of the Liver Center at University of Kansas, Kansas City, Kansas), Cardax evaluated the capacity for a proprietary astaxanthin (ASTX) prodrug...

Newsroom

Cardax News and Media

Company Overview

About Astaxanthin

All Press Releases

View all Media Coverage

Contact Us

Recent Press Releases

Management Insights and Media Coverage

New Clinical Trial Studies Cardio-Inflammatory Health

Cardax CEO Featured on Big Biz TV Show

Setting the record straight about ZanthoSyn®

The Secret to a Longer Life

NIH selection propels Cardax towards expansion

Compound boosts gene related to longevity, UH researchers find

Promising anti-aging gene therapy developed through innovative partnership

Extending human life: UH scientists announce new research

UH study: Compound found in seafood, algae ‘activates’ longevity gene

Cardax’s Proprietary Astaxanthin Prodrug (CDX-085) Accumulates in Liver, Reduces Elevated Liver Enzymes, and Attenuates Pathohistological Alterations in a Model of Alcohol-Induced Hepatic Stress

Company Contact

About Cardax

Recent News

Quick Links

Contact Us